Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6WLA

Antigen binding fragment of ch128.1

This is a non-PDB format compatible entry.
Summary for 6WLA
Entry DOI10.2210/pdb6wla/pdb
DescriptorFab ch128.1 heavy chain, Fab ch128.1 light chain, GLYCEROL, ... (4 entities in total)
Functional Keywordsantibody, anti-hutfr1, immune system
Biological sourceHomo sapiens (Human)
More
Total number of polymer chains6
Total formula weight141144.87
Authors
Helguera, G.,Rodriguez, J.A.,Sawaya, M.,Cascio, D.,Zink, S.,Ziegenbein, J.,Short, C. (deposition date: 2020-04-18, release date: 2021-03-24, Last modification date: 2024-10-16)
Primary citationHickerson, B.T.,Daniels-Wells, T.R.,Payes, C.,Clark, L.E.,Candelaria, P.V.,Bailey, K.W.,Sefing, E.J.,Zink, S.,Ziegenbein, J.,Abraham, J.,Helguera, G.,Penichet, M.L.,Gowen, B.B.
Host receptor-targeted therapeutic approach to counter pathogenic New World mammarenavirus infections.
Nat Commun, 13:558-558, 2022
Cited by
PubMed Abstract: Five New World mammarenaviruses (NWMs) cause life-threatening hemorrhagic fever (HF). Cellular entry by these viruses is mediated by human transferrin receptor 1 (hTfR1). Here, we demonstrate that an antibody (ch128.1/IgG1) which binds the apical domain of hTfR1, potently inhibits infection of attenuated and pathogenic NWMs in vitro. Computational docking of the antibody Fab crystal structure onto the known structure of hTfR1 shows an overlapping receptor-binding region shared by the Fab and the viral envelope glycoprotein GP1 subunit that binds hTfR1, and we demonstrate competitive inhibition of NWM GP1 binding by ch128.1/IgG1 as the principal mechanism of action. Importantly, ch128.1/IgG1 protects hTfR1-expressing transgenic mice against lethal NWM challenge. Additionally, the antibody is well-tolerated and only partially reduces ferritin uptake. Our findings provide the basis for the development of a novel, host receptor-targeted antibody therapeutic broadly applicable to the treatment of HF of NWM etiology.
PubMed: 35091550
DOI: 10.1038/s41467-021-27949-3
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.6 Å)
Structure validation

247947

PDB entries from 2026-01-21

PDB statisticsPDBj update infoContact PDBjnumon